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Introduction
Urinary incontinence (UI) is a common problem affecting 
between 12.8% and 46.0% of adult women [1]. Stress uri-
nary incontinence (SUI), frequently occurs among healthy 
women—approximately 30% of these women are aged <30 
years and 14% to 41% of these women are aged 30 to 60 
years. The prevalence of UI increases with age, ranging from 
12.2% in women aged 60 to 64 years to 20.9% in those 
aged >85 years [2]. The midurethral sling (MUS) is the treat-
ment of choice for SUI as it is minimally invasive, associated 
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Objective
We compared the outcomes of the midurethral sling (MUS) with and without concomitant prolapse repair.
Methods 
We retrospectively reviewed the outcomes of 203 women who underwent MUS at Severance Hospital from January 
2009 to April 2012 with and without concomitant prolapse repair. Patients completed the urogenital distress inventory 
questionnaire preoperatively and postoperatively. The outcomes were assessed by using validated questionnaires and 
reviewing medical records. McNemar’s test, t-test, and multiple logistic regression were used for analysis. 
Results
We noted that women who underwent MUS alone were more likely to experience urinary frequency (12% vs. 25%, 
P = 0.045), urgency (6% vs. 24%, P< 0.001), and bladder emptying difficulty (2% vs. 10%, P = 0.029) compared to 
those who underwent concomitant repair. Women who only MUS were more likely to experience discomfort in the 
lower abdominal or genital region compared to those who than those who underwent concomitant repair; however, 
the difference was not significant (5% vs. 11%, P = 0.181). In the MUS only group, maximal cystometric capacity 
(MCC)  was a significant parameter of preoperative and postoperative urinary frequency (P = 0.042; odds ratio, 0.994; 
P = 0.020; odds ratio, 0.993), whereas the Valsalva leak point pressure (VLPP) was a significant factor of postoperative 
bladder emptying difficulty (P=0.047; odds ratio, 0.970). 
Conclusion 
The outcomes did not differ between patients who underwent MUS alone and those with concomitant repair. In the 
MUS only group, MCC and VLPP were significant urodynamics study parameters related to urinary outcome. 
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with a shorter recovery times, and results in fewer periopera-
tive complications [3,4]. Moreover, pelvic organ prolapse (POP) 
is often a comorbid condition in women with UI and reportly 
occurs in 15% to 80% of UI patients [5].
Thus, several studies have been conducted to determine 
whether concomitant POP repair is effective for patients with 
SUI. Researchers have hypothesized that damage to similar 
anatomical structures leads to the loss of both pelvic support 
and continence; however, this hypothesis does not explain the 
underlying cause among those women who experience pro-
lapse or incontinence alone. In a study conducted by Richter 
et al. [6], women with preexisting SUI at the time of prolapse 
repair had significantly lower urinary tract symptoms, suggest-
ing that concomitant SUI and prolapse represent a marker for 
more severe pelvic floor disorders.
However, some studies have described the outcomes of 
MUS and concomitant prolapse repair in patients with SUI 
and have indicated that efficacy and improvement in quality 
of life in these patients is similar to that in patients treated 
with MUS alone [7-9]. However, the data on patients with 
mixed UI who are treated with MUS and concomitant POP 
repair are scarce. Thus, the efficacy of concomitant surgery 
remains controversial.
In the present study, we compared the urinary outcomes be-
tween patients with UI who underwent MUS alone and those 
with POP who underwent MUS with concomitant prolapse 
repair. Moreover, we also examined the effect of concomitant 
surgery on postoperative urinary outcomes. In addition, we 
performed urodynamic studies (UDS) preoperatively, and the 
relationship between UDS parameters and postoperative uri-
nary outcomes was assessed.
Materials and methods
In this retrospective cohort study, we included 212 patients 
who underwent MUS, involving the use of a transobturator 
tape, with and without concomitant prolapsed repair from 
January 2009 to April 2012 at Yonsei University Severance Hos-
pital. Among these patients, 9 patients were excluded for the 
following reasons: did not undergo UDS preoperatively, lack of 
urogenital distress (UDI-6) data, or loss to follow‐up. Eventually, 
the medical records of 203 patients were reviewed.
The UI in patients was preoperatively confirmed by physical 
examination, and also on the findings of UDS in cases where 
it was indicated. Physical examination included prolapse, 
atrophy, levator muscle palpation (symmetry and ability to 
squeeze), anal sphincter function, and the Q-tip test. 
All the patients underwent surgery via the vaginal approach. 
However, patients who underwent MUS with POP repair were 
excluded. The objective outcomes were assessed by UDS 
findings, blood loss, duration of hospital stay, operative time, 
and pre/post POP-Q staging. The subjective outcomes were 
assessed using the UDI-6 questionnaire. The short form of the 
UDI-6 was completed during the preoperative and postopera-
tive assessments. Patient demographics were recorded for the 
assessment of preoperative, intra-operative, and postoperative 
parameters. The UDI-6 is a validated condition-specific ques-
tionnaire that has been used in patients undergoing pelvic 
reconstructive surgery to compare the preoperative and post-
operative patient status. The questionnaire contains 6 ques-
tions that assess the degree to which a patient is affected 
by symptoms such as UI (question 1), SUI (question 2), urge 
incontinence (question 3), small amounts of urinary leaking 
(question 4), difficulty in bladder emptying (question 5), and 
pelvic pain/discomfort (question 6). Patients completed the 
UDI-6 at 4 months postoperatively. Pelvic examination was 
performed at 1, 4, and 6 months postoperatively. The patients 
were also assessed for POP-Q staging, dehiscence, and opera-
tive site bleeding.
All 203 patients underwent UDS preoperatively, and six 
parameters were compared to determine a significant differ-
ence in the outcomes between patients undergoing MUS with 
and without concomitant prolapse repair. These parameters 
included the Valsalva leak point pressure (VLPP), maximal 
urethral closing pressure (MUCP), maximal flow rates (Qmax), 
detrusor pressure at maximal flow (PdetMax), maximal cysto-
metric capacity (MCC), and postvoidal residual volume (PVR). 
Data were analyzed using McNemar’s test and the two-
sample t-test. Patient demographics and clinical characteristics 
were controlled. If the P-value was <0.1 on univariate analysis, 
multivariate logistic regression was performed to determine the 
effect of concomitant POP on the outcomes of MUS. Institu-
tional review board approval was obtained for this study.
Results
In total, 203 of the 212 (95%) women who underwent MUS 
between January 2009 and April 2012 completed the follow-
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up survey and were included in the study. Of these women, 
114 (56%) underwent MUS only and 98 (48%) underwent 
MUS with concomitant pelvic floor repair. The women in the 
concomitant repair group were significantly older than those 
in the MUS only group (median age, 61 vs. 54 years, respec-
tively; P < 0.001). Moreover, the women in the concomitant 
repair group showed increased parity (4.5 vs. 3.8, P = 0.017), 
diabetes mellitus (11.2 vs. 3.5, P = 0.029), hypertension (48.0 
vs. 23.7, P < 0.001), mixed UI (20 vs. 5, P < 0.001), require-
ment of anti-cholinergic medication (21 vs. 9, P = 0.009), and 
incidence of having home delivery or difficult labor (39 vs. 
19, P < 0.001) as compared to those in the MUS procedure 
only group, respectively. The groups did not significantly dif-
fer in terms of body mass index, body weight or prior pelvic 
surgery (Table 1). In the concomitant repair group, the most 
common type of POP-Q staging was IIIBa (39 women, 41%). 
The second-most common type of POP-Q staging was IVC 
(18 women, 14%) (Fig. 1). In addition, the women underwent 
concomitant repair had a significantly longer duration of hos-
pital stay (6.7 ± 2.4 vs. 3.1 ± 0.6, P < 0.001), and increased 
Table 1. Differences in the characteristics between the mid-urethral sling (MUS) only group and the MUS with concomitant repair group
Variable MUS with concomitant repair group MUS only group P-value
No. of patients 98 114
Age (yr)   62.0 ± 10.8 54.0 ± 8.3 <0.001
Body mass index (kg/m2) 24.4 ± 2.7   27.2 ± 19.7 0.138
Body weight (kg) 59.5 ± 7.8 60.0 ± 8.5 0.646
Parity   4.5 ± 2.2     3.8 ± 2.2 0.017
Home delivery   39 (39.8)   19 (17.2) <0.001
Difficult labor   51 (52.0)   19 (17.3) <0.001
Medical illness history
Hypertension   47 (48.0)  27 (23.7) <0.001
Diabetes mellitus   11 (11.2)  4 (3.5) 0.029
Asthma   3 (3.1) 0 (0) 0.060
Other   23 (23.5)  28 (24.6) 0.853
Previous operative history     
Hysterectomy       12 (112.2)       21 (18.6) 0.206
Previous prolapse OP        0 (0)            3 (2.7) 0.250
LBTL      6 (6.1)       3 (2.7) 0.309
Other      5 (5.1)     10 (8.9) 0.291
Mixed UI type      20 (20.4)       5 (4.4) <0.001
Anti-cholinergics medication      21 (21.4)       9 (8.8) 0.009
Preoperative UDS parameters
VLPP (cmH2O) 92.2 ± 1.8   91.7 ± 1.8 0.694
MUCP (cmH2O) 52.6 ± 1.9   52.7 ± 1.9 0.960
Qmax (mL/sec) 22.5 ± 0.8   22.4 ± 0.9 0.923
PdetMax (cmH2O) 28.7 ± 1.8   31.3 ± 1.9 0.287
MCC (mL) 443.1 ± 7.8 423.6 ± 9.6 0.092
PVR (mL) 26.0 ± 3.9   15.5 ± 2.9 0.041
Values are presented as mean ± standard deviation or number (%).
The two sample t-test and chi-square or Fisher’s exact test were used.
MUS, midurethral sling; OP, operation; LBTL, laparoscopic-bilateral tubal ligation; UI, urinary incontinence; UDS, urodynamics study; VLPP, 
Valsalva leak point pressure; MUCP, maximal urethral closing pressure; Qmax, maximal flow rates; PdetMax, detrusor pressure at maximal 
flow; PVR, postvoidal residual volume.
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blood loss (<50 mL; 81 vs. 114, P < 0.001), and operative 
time (120.9 ± 55.9 vs. 33.9 ± 10.5, P < 0.001) compared to 
the MUS only group, respectively.
The MUS only group had a higher mean total UDI-6 scores 
as compared to the concomitant repair group, although 
this difference was not statistically significant (2.6 ±2.0 vs. 
2.3 ± 2.1, respectively; P = 0.203).
The postoperative total UDI-6 scores were significantly 
higher in the MUS only group than in the concomitant repair 
group (0.9 ±1.6 vs. 0.3 ± 0.9, respectively; P < 0.001). Women 
who underwent MUS only tended to be affected by urinary 
urgency to a greater extent preoperatively and postopera-
tively (54% vs. 34%, respectively; P = 0.031; 24% vs. 6%, 
respectively; P < 0.001) and were more likely to experience in 
difficulty emptying the bladder postoperatively (10% vs. 2%, 
P = 0.029) compared to those who underwent concomitant 
repair, respectively.
In addition, the patients who underwent MUS only indi-
cated a significantly greater difficulty in bladder emptying 
than those who underwent concomitant repair (2% vs. 
10%, respectively; P = 0.029). Women who underwent MUS 
only were more likely to experience discomfort in the lower 
abdominal or genital region as compared to those who un-
derwent concomitant repair, although this difference was not 
significant (5% vs. 11%, respectively; P = 0.181) (Tables 2, 3). 
On postoperative pelvic examination, only 1patient showed 
recurrence (preoperative POP-Q staging, IVC; postoperative 
POP-Q staging, IIAp).
We compared 6 preoperative UDS parameters (VLPP, MUCP, 
Qmax, PdetMax, MCC, and PVR) to determine the significant 
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Fig. 1. Preoperative pelvic organ prolapsed (POP)-Q staging of the midurethral sling with concomitant repair group. a)POP-Q 
stage. 0: No prolapse is demonstrated. Points Aa, Ap, Ba, and Bp are all at -3 cm, and point C is between the total 
vaginal length (TVL) and TVL -2 cm. I: The most distal portion of the prolapse is >1 cm above the level of the hymen. 
II: The most distal portion of the prolapse is <1 cm proximal or distal to the plane of the hymen. III: The most distal 
portion of the prolapse is <1 cm below the plane of the hymen but no further than 2 cm less than the TVL. IV: Com-
plete to nearly complete eversion of the vagina. The most distal portion of the prolapsed protrudes to more than (TVL–2) 
cm. Aa: Anterior wall 3 cm from the hymen, -3 cm to +3 cm. Ba: Most part of the rest of the anterior wall, -3 cm to 
+TVL. C: Cervix or vaginal cuff ±TVL. D: Posterior fornix (if no prior total hysterectomy) ±TVL. Ap: Posterior wall 3cm 
from the hymen, -3 cm to +3 cm. Bp: Most part of the rest of the posterior wall, -3 cm to +TVL.
POP- a)
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differences in the outcomes between the 2 groups. MCC was 
found to be a significant parameter for urinary frequency, 
both preoperatively and postoperatively (P = 0.042; odds ra-
tio, 0.994; P = 0.020; odds ratio, 0.993). Moreover, VLPP was 
found to be a significant factor for postoperative difficulty in 
bladder emptying (P = 0.047; odds ratio, 0.970). The differ-
Table 2. Preoperative UDI-6 scores of the MUS only group and MUS with concomitant repair group
Variable MUS with concomitant repair group MUS only group P-value
Question 1a)      48 (50.0) 59 (55.1) 0.464
Question 2b)   34 (35.4) 54 (50.5) 0.031
Question 3c) 38 (39.9) 73 (68.2) <0.001
Question 4d) 34 (35.4) 57 (53.3) 0.011
Question 5e) 31 (32.3) 14 (13.1) <0.001
Question 6f) 33 (34.4) 25 (23.4) 0.083
Total UDI-6 score 2.3 ± 2.1   2.6 ± 2.0 0.203
Values are presented as mean ± standard deviation or number (%).
The two sample t-test and chi-square or Fisher’s exact test were used.
UDI, urogenital distress inventory; MUS, midurethral sling.
The UDI-6 questionnaire consists of six questions: a)Do you experience, and if so, how much are you bothered by frequent urination?; b)Do 
you experience, and if so, how much are you bothered by urine leakage related to physical activity, coughing, or sneezing?; c)Do you expe-
rience, and if so, how much are you bothered by urine leakage related to the feeling of urgency?; d)Do you experience, and if so, how much 
are you bothered by small amount of urine leakage (drops)?; e)Do you experience, and if so, how much are you bothered by small amount 
of urine leakage (drops)?; f)Do you experience, and if so, how much are you bothered by pain or discomfort in the lower abdominal or 
genital area?
Table 3. Outcomes of the MUS only group and the MUS with concomitant repair group
Variable MUS with concomitant repair group MUS only group P-value
Question 1a)       12 (12.5)     25 (23.4) 0.045
Question 2b)     6 (6.3)      24 (22.4) <0.001
Question 3c)     4 (4.2)     13 (12.2) 0.040
Question 4d)     2 (2.1)     16 (15.0) <0.001
Question 5e)     2 (2.1)   10 (9.4) 0.029
Question 6f)     5 (5.2)     11 (10.3) 0.181
Total UDI-6 score   0.3 ± 0.9   0.9 ± 1.6 <0.001
Hospital days (day)   6.7 ± 2.4   3.1 ± 0.6 <0.001
OP time (min)   120.9 ± 55.9   33.9 ± 10.6 <0.001
Blood loss (mL) <0.001
<50       81 (82.7)       114 (100.0)
<100       9 (9.2)       0 (0.0) 
<200       8 (8.2)       0 (0.0)
Values are presented as mean ± standard deviation or number (%).
MUS, midurethral sling; UDI, urogenital distress inventory; OP, operative.
The UDI-6 questionnaire consists of six questions: a)Do you experience, and if so, how much are you bothered by frequent urination?; b)Do 
you experience, and if so, how much are you bothered by urine leakage related to physical activity, coughing, or sneezing?; c)Do you expe-
rience, and if so, how much are you bothered by urine leakage related to the feeling of urgency?; d)Do you experience, and if so, how much 
are you bothered by small amount of urine leakage (drops)?; e)Do you experience, and if so, how much are you bothered by small amount 
of urine leakage (drops)?; f)Do you experience, and if so, how much are you bothered by pain or discomfort in the lower abdominal or 
genital area?
www.ogscience.org 55
E Jung Han, et al. Midurethral sling and concomitant prolapse repair
Table 4. Correlations between UDS parameters and preoperative UDI-6 scores in the MUS only group (group A) and the MUS with con-
comitant repair group (group B)
Variable
 Group A  Group B 
MUCP PVR MCC PVR VLPP
Question 1a)     0.994 (0.988−0.999)* P = 0.042    
Question 2b)     0.982 (0.958−1.007)* P = 0.159  
Question 3c)      
Question 4d)      
Question 5e) 0.967 (0.934−1.001)*P =0.056    
Question 6f)   1.004 (0.991−1.017)*P = 0.524  
0.969(0.923−1.101)*
P = 0.255
1.102(0.993−1.056)*
P = 0.231
Data are expressed as odds ratios (95% confidence intervals) and P-values. 
The factors that were significantly different between the two groups (Table 1) were corrected.
UDS, urodynamics study; UDI, urogenital distress inventory; MUS, midurethral sling; MUCP, maximal urethral closing pressure; PVR, post-
void residual volume; MCC, maximal cystometric capacity; VLPP, Valsalva leak point pressure.
*Multiple logistic regression was used if the P-value <0.1 in the univariate analysis.
The UDI-6 questionnaire consists of six questions: a)Do you experience, and if so, how much are you bothered by frequent urination?; b)Do you 
experience, and if so, how much are you bothered by urine leakage related to physical activity, coughing, or sneezing?; c)Do you experience, and 
if so, how much are you bothered by urine leakage related to the feeling of urgency?; d)Do you experience, and if so, how much are you bothered 
by small amount of urine leakage (drops)?; e)Do you experience, and if so, how much are you bothered by small amount of urine leakage (drops)?; 
f)Do you experience, and if so, how much are you bothered by pain or discomfort in the lower abdominal or genital area?
Table 5. Correlations between UDS parameters and postoperative UDI-6 scores in the MUS only group (group A) and MUS with concomi-
tant repair group (group B)
Variable
 Group A  Group B 
Qmax MCC VLPP MCC
Question 1a) 1.091 (0.989−1.204)* 
P = 0.083
     0.993 (0.987−0.999)* 
P = 0.020
Question 2b)   1.031 (0.996−1.067)* P = 0.079  
Question 3c)     0.970 (0.941−0.999)* 
P = 0.047
Question 4d)     0.994 (0.987−1.001)* P = 0.870
Question 5e)      
Question 6f)        
Data are expressed as odds ratios (95% confidence intervals) and P-values.
The factors that were significantly different between the two groups (Table 1) were corrected.
UDS, urodynamics study; UDI, urogenital distress inventory; MUS, midurethral sling; Qmax, maximal flow rates; MCC, maximal cystometric 
capacity; VLPP, Valsalva leak point pressure.
*Multiple logistic regression was used if the P-value <0.1 in the univariate analysis.
The UDI-6 questionnaire consists of six questions: a)Do you experience, and if so, how much are you bothered by frequent urination?; b)Do you 
experience, and if so, how much are you bothered by urine leakage related to physical activity, coughing, or sneezing?; c)Do you experience, and if 
so, how much are you bothered by urine leakage related to the feeling of urgency?; d)Do you experience, and if so, how much are you bothered 
by small amount of urine leakage (drops)?; e)Do you experience, and if so, how much are you bothered by small amount of urine leakage (drops)?; 
f)Do you experience, and if so, how much are you bothered by pain or discomfort in the lower abdominal or genital area?
www.ogscience.org56
Vol. 57, No. 1, 2014
ences in the other parameters between the 2 groups were not 
significant (Tables 4, 5).
Discussion
UI has been reported to coexist with POP in 15% to 80% of 
cases [5]. The treatment of coexisting POP when performing 
the MUS procedure for SUI has been found to be effective, and 
yields a similar improvement in symptoms compared to cases 
undergoing MUS alone [7-11]. Sokol et al. [12] and Yip and 
Pang [13] did not identify any significant difference in SUI cure 
rates between women who underwent concomitant prolapse 
repair during transvaginal tape and those who did not. Our 
data indicated a similar outcome with regard to UI cure rates 
with MUS during POP repair. Women who underwent MUS 
only tended to be affected by urinary frequency to a greater 
extent (12% vs. 25%, P = 0.045) and were more likely to have 
urgency (6% vs. 24%, P < 0.001) as compared to those who 
also underwent concomitant POP repair, respectively.
Despite the high success rates achieved when concurrently 
treating UI and POP, Huang et al. [10] and Partoll [11] re-
ported that concomitant surgery causes postoperative side 
effects such as voiding difficulty, bladder outlet obstruction, 
and overactive bladder. Interestingly, the present data in-
dicated that patients who underwent MUS only, exhibited 
a significantly greater difficulty in bladder emptying than 
those who underwent concomitant POP repair (2% vs. 10%, 
respectively; P = 0.029). Moreover, women who underwent 
MUS only were more likely to experience discomfort in the 
lower abdominal or genital region than those who underwent 
concomitant repair, although this difference was not signifi-
cant (5% vs. 11%, respectively; P = 0.181). Thus, our data in-
dicate that the outcomes did not differ between the MUS only 
group and the MUS and concomitant repair group.
The effect of UDS findings on the choice, or outcome of 
surgery remains controversial. Several studies have assessed 
the efficacy of preoperative UDS parameters; in general, pa-
tients with higher preoperative MUCP values are known to 
have better surgical outcomes. 
Moreover,the predictive value of VLPP is inconsistent. 
Kilicarslan et al. [14] noted that high VLPP scores were as-
sociated with better outcomes, whereas other studies have 
failed to prove any effect of preoperative leak point pres-
sures on surgical outcomes [15,16]. Certain Korean doctors 
indicated that patients with preoperative Qmax <15 mL/
sec have a tendency to experience postoperative voiding 
dysfunction [17]. However, other researchers have insisted 
that preoperative UDS parameters are not associated with 
postoperative urinary outcomes [18], whereas other studies 
have not shown any differences in surgical outcomes based 
on preoperative UDS parameters [19,20]. Despite the con-
flicting results of these studies, UDS is considered the most 
accurate method for predicting surgical outcomes. The data 
in the present study indicated that MCC was a statistically 
significant parameter of urinary frequency, both preopera-
tively and postoperatively (P  = 0.042; odds ratio, 0.994; 
P = 0.020; odds ratio, 0.993). The VLPP was a statistically 
significant parameter of postoperative bladder emptying dif-
ficulty (P = 0.047; odds ratio, 0.970) in the MUS only group. 
Thus, these findings indicate that the preoperative UDS pa-
rameters of MCC, and VLPP could predict the outcomes of 
concomitant surgery.
The strengths of the present study included the larger 
sample size as compared to previous studies and the use of 
the short form of the UDI-6 for quantifying the subjective 
symptoms of patients. In addition, all surgeries were per-
formed by the same surgeon at the same hospital, and we 
compared patients at similar POP-quantification stages. To 
our knowledge, the present study is the first to compare the 
outcomes of MUS with and without concomitant prolapse 
repair in Korean patients. However, 1 limitation of the pres-
ent study should be carefully considered. The surgical out-
comes could differ according to the type of anterior repair, 
posterior repair, or apical suspension; however, our study 
was insufficiently powered to assess these subgroups.
In conclusion, no differences were observed in the out-
comes of patients in the MUS only group and those in the 
MUS with concomitant repair group. In the MUS only group, 
MSS and VLPP were the UDS parameters that were signifi-
cant predictors of urinary outcome. Although the investiga-
tions on this topic are ongoing, the findings remain contro-
versial. Therefore, additional studies on related aspects are 
required to evaluate the postoperative urinary outcomes. 
Moreover, a larger number of patients should be included in 
future long-term studies to objectively assess the effective-
ness and outcomes of MUS with and without concomitant 
prolapse repair.
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